Rilutek

Pharma

Mitsubishi's Radicava ready to roll with ALS nod

The FDA actually invited Mitsubishi Tanabe to file Radicava for U.S. approval based on data generated in Japan. Now, it's the first new ALS med in decades.

Eric Sagonowsky May 8, 2017 10:45am

Mitsubishi Tanabe eyes 2017 U.S. approval for edaravone in ALS

Sep 1, 2016 7:56am